NCT06001736 Utility of CC7 Transfer in Stroke Subtypes
| NCT ID | NCT06001736 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dartmouth-Hitchcock Medical Center |
| Condition | Stroke, Ischemic |
| Study Type | INTERVENTIONAL |
| Enrollment | 95 participants |
| Start Date | 2022-03-13 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 95 participants in total. It began in 2022-03-13 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the limb functional improvement after contralateral C7 root transfer in stroke patients.
Eligibility Criteria
Inclusion Criteria: * History of ischemic or hemorrhagic stroke with resultant arm paresis that has ceased to improve within 1-5 years of rehabilitation. * baseline Fugl-Meyer score below 33 Exclusion Criteria: * pregnancy
Contact & Investigator
Jennifer Hong, Dr.
PRINCIPAL INVESTIGATOR
Dartmouth-Hitchcock Medical Center
Frequently Asked Questions
Who can join the NCT06001736 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Stroke, Ischemic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06001736 currently recruiting?
Yes, NCT06001736 is actively recruiting participants. Contact the research team at Lauren.J.Sinks@hitchcock.org for enrollment information.
Where is the NCT06001736 trial being conducted?
This trial is being conducted at Lebanon, United States.
Who is sponsoring the NCT06001736 clinical trial?
NCT06001736 is sponsored by Dartmouth-Hitchcock Medical Center. The principal investigator is Jennifer Hong, Dr. at Dartmouth-Hitchcock Medical Center. The trial plans to enroll 95 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.